187 related articles for article (PubMed ID: 9257875)
1. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1997 Aug; 55(4):169-74. PubMed ID: 9257875
[TBL] [Abstract][Full Text] [Related]
2. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
3. Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor.
Takahashi H; Sato N; Shibata A
Thromb Res; 1995 Nov; 80(4):339-48. PubMed ID: 8585047
[TBL] [Abstract][Full Text] [Related]
4. Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation.
Yamamuro M; Wada H; Kumeda K; Inoue A; Tsuji I; Nakasaki T; Shimura M; Hiyoyama K; Gabazza EC; Nishikawa M; Deguchi K; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1998 Sep; 9(6):491-7. PubMed ID: 9818999
[TBL] [Abstract][Full Text] [Related]
5. Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Nakasaki T; Hiyoyama K; Mori Y; Nishikawa M; Deguchi H; Deguchi K; Gabazza EC; Shiku H
Am J Hematol; 1999 Feb; 60(2):94-8. PubMed ID: 9929099
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].
Saito M; Morishita E; Asakura H; Jokaji H; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Matsuda T
Rinsho Ketsueki; 1996 Sep; 37(9):794-8. PubMed ID: 8914465
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation.
Okugawa Y; Wada H; Noda T; Sakakura M; Nakasaki T; Watanabe R; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Nobori T; Shiku H
Am J Hematol; 2000 Nov; 65(3):210-4. PubMed ID: 11074537
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor response does not correlate with tissue factor-induced disseminated intravascular coagulation and multiple organ dysfunction syndrome in trauma patients.
Gando S; Nanzaki S; Morimoto Y; Ishitani T; Kemmotsu O
Crit Care Med; 2001 Feb; 29(2):262-6. PubMed ID: 11246303
[TBL] [Abstract][Full Text] [Related]
11. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients.
Gando S; Kameue T; Matsuda N; Hayakawa M; Morimoto Y; Ishitani T; Kemmotsu O
Thromb Res; 2003 Jan; 109(2-3):119-24. PubMed ID: 12706640
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of free tissue factor pathway inhibitor antigen in cases of disseminated intravascular coagulation caused by various underlying diseases.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Morishita E; Yamazaki M; Suga Y; Takami A; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2001 Jan; 12(1):1-8. PubMed ID: 11229821
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
14. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
15. Expression of tissue factor and tissue factor pathway inhibitor in rats lungs with lipopolysaccharide-induced disseminated intravascular coagulation.
Hara S; Asada Y; Hatakeyama K; Marutsuka K; Sato Y; Kisanuki A; Sumiyoshi A
Lab Invest; 1997 Dec; 77(6):581-9. PubMed ID: 9426395
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium.
Kuczyński J; Uszyński W; Zekanowska E; Soszka T; Uszyński M
Eur J Obstet Gynecol Reprod Biol; 2002 Oct; 105(1):15-9. PubMed ID: 12270558
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor in plasma of patients with disseminated intravascular coagulation.
Takahashi H; Satoh N; Wada K; Takakuwa E; Seki Y; Shibata A
Am J Hematol; 1994 Aug; 46(4):333-7. PubMed ID: 8037186
[TBL] [Abstract][Full Text] [Related]
18. Tissue factor pathway inhibitor (TFPI) in disseminated intravascular coagulation: low levels of the activated factor X-TFPI complex.
Iversen N; Strekerud FG; Abildgaard U
Blood Coagul Fibrinolysis; 2000 Oct; 11(7):591-8. PubMed ID: 11085278
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation.
Wada H; Nakase T; Nakaya R; Minamikawa K; Wakita Y; Kaneko T; Ohiwa M; Deguchi K; Shirakawa S
Am J Hematol; 1994 Mar; 45(3):232-6. PubMed ID: 8296794
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
